fentaNYL CITRATE 4 MCG/mL in 0.9% SODIUM CHLORIDE Injection, in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999993491
Published July 13, 2016 · Recall initiated: August 21, 2015
Summary
FDA records drug Class I recall D-1157-2016, published July 13, 2016 and initiated August 21, 2015. Recalling firm: Cantrell Drug Company; Status: Terminated; Reported quantity: 148 syringes; Lot: Lot: 150370, exp 1/2/16. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cantrell Drug Company
- Distributor
- Nationwide
- Lot
- Lot: 150370, exp 1/2/16
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEphedrine Sulfate in 0.9% Sodium Chloride 5 mL, 50 mg/5 mL (10 mg/mL) Single-Dose Syringe, Rx Only, CantrellAugust 16, 2017
- FDAGlycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell DrugAugust 16, 2017
- FDAPhenylephrine HCL in 0.9% Sodium Chloride 10 mL, 1 mg/10 mL (100 mcg/mL) Single-Dose Syringe, Rx Only,August 16, 2017
- FDANeostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Dose Syringe, Rx Only, CantrellAugust 16, 2017
- FDAfentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDCJuly 13, 2016
- FDAfentaNYL Citrate 50 mcg/mL in Sterile Water for Injection, packaged in 2 mL syringe, Rx Only, Cantrell DrugJuly 13, 2016
Questions about this recall
Was fentaNYL CITRATE 4 MCG/mL in 0.9% SODIUM CHLORIDE Injection, in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999993491 recalled?
Yes. FDA published recall D-1157-2016 on July 13, 2016. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail